DUFU technology product used for Covid-19 detection?
https://dufutechnology.com/contamination-control/
Spectrophotometer, FTIR for Organic materials analysis
................
Researchers Race to Advance Viral Disease Identification as COVID-19 Spreads
5 March 2020
https://www.bloomberg.com/press-releases/2020-03-05/researchers-race-t...
Todos Medical Ltd. (OTCQB: TOMDF) announced earlier this week the "publication of data from a human clinical study in the scientific journal Analytical Chemistry entitled 'Differential Diagnosis of the Etiologies of Bacterial and Viral Infections Using Infrared Microscopy of Peripheral Human Blood Samples and Multivariate Analysis'. The data demonstrate that the use of the Fourier-transform infrared (FTIR) spectroscopy technique on peripheral blood samples yields a differential diagnosis when seeking to make a clinical diagnosis between patients with viral infections, bacterial infections and healthy controls.
'With the recent explosion of novel coronavirus (2019-nCoV) worldwide, definitively diagnosing viral infections versus bacterial or other types of infections that present with similar symptoms has become paramount in order to appropriately triage patients and guide treatment decisions for healthcare professionals,' said Gerald Commissiong, President & CEO of Todos Medical.
'Todos' proprietary FTIR blood testing platform that focuses on the immune system's reaction to cancer has received CE Marks in Europe for the diagnosis of breast cancer and colon cancer, has recently achieved strong analytical performance results from our proprietary sample preparation methods, and is currently enrolling a pre-commercial breast cancer study in Romania with distribution partner Orot+ (a division of Orot Luces) ahead of an expected commercial launch in Romania later this year.
Based on these recent successes and this publication from the Company's licensors at Ben Gurion University, we have now formally begun to evaluate the commercial feasibility of applying our technology towards the diagnosis of bacterial and viral infections, including coronavirus.
............
[DUFU] Notice of Interest of Substantial Shareholders - EASTSPRING INVESTMENTS BERHAD on 03-Apr-2020
Total no of securities after change
Direct (units) 12,898,620
Direct (%) 5.03
https://klse.i3investor.com/blogs/2017/2020-04-04-story-h1485792390-DUFU_technology_product_used_for_Covid_19_detection.jsp
